SGRY — Surgery Partners Balance Sheet
0.000.00%
- $2.21bn
- $7.39bn
- $3.11bn
- 60
- 89
- 28
- 63
Annual balance sheet for Surgery Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 318 | 390 | 283 | 196 | 270 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 382 | 430 | 456 | 496 | 579 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 802 | 946 | 921 | 895 | 1,119 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 855 | 954 | 1,156 | 1,224 | 1,384 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,413 | 6,118 | 6,682 | 6,877 | 7,890 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 557 | 537 | 493 | 523 | 624 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,863 | 5,029 | 4,684 | 4,890 | 6,100 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 550 | 1,089 | 1,998 | 1,987 | 1,790 |
| Total Liabilities & Shareholders' Equity | 5,413 | 6,118 | 6,682 | 6,877 | 7,890 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |